We successfully demonstrated by ISH analysis that the H19 gene is expressed in 65% of the analyzed human pancreatic cancer samples (n = 49, Figure 1), indicating that treatment of human pancreatic cancer with the DTA-H19 is very likely to be effective in this disease. Here, H19 is linked to pancreatic neoplasm.